Table 2:
dnDSA Characteristics of Study Population
Characteristics | dnDSA+ (n=145) | Early Treatment (n=30) | No Early Treatment (n=115) |
---|---|---|---|
| |||
Median days to dnDSA | 38 | 11 | 75 |
| |||
HLA Class I | 12 (8%) | 3 (10%) | 9 (8%) |
| |||
HLA Class II | 110 (76%) | 16 (53%) | 94 (81%) |
DQ | 89 (61%) | 13 (43%) | 76 (66%) |
DP/DR | 12 (8%) | 3 (10%) | 9 (8%) |
DQ + DP/DR | 9 (8%) | 0 | 9 (8%) |
| |||
HLA Class I and II | 17 (12%) | 6 (20%) | 11 (10%) |
| |||
Other Combinations | 6 (4%) | 5 (17%) | 1 (1%) |